Norio Tada

Norio Tada

Auto-generated profile, based on publicly available information

Norio Tada

Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
HHHiromu Hase
Hiromu Hase
NYNobuhiro Yoshijima
Nobuhiro Yoshijima
RYRyo Yanagisawa
Ryo Yanagisawa
MTMakoto Tanaka
Makoto Tanaka
HTHikaru Tsuruta
Hikaru Tsuruta
OIOCEAN‐TAVI Investigators
OCEAN‐TAVI Investigators

11 April 2019 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
NYNobuhiro Yoshijima
Nobuhiro Yoshijima
RYRyo Yanagisawa
Ryo Yanagisawa
HHHiromu Hase
Hiromu Hase
MTMakoto Tanaka
Makoto Tanaka
HTHikaru Tsuruta
Hikaru Tsuruta
OIOn behalf of the OCEAN‐TAVI investigators
On behalf of the OCEAN‐TAVI investigators

6 October 2021 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
SMShingo Matsumoto
Shingo Matsumoto
YOYohei Ohno
Yohei Ohno
JMJunichi Miyamoto
Junichi Miyamoto
YIYuji Ikari
Yuji Ikari
NTNorio Tada
Norio Tada
TIThe OCEAN‐TAVI Investigators
The OCEAN‐TAVI Investigators

18 March 2021 in Open Heart
Verified
Journal Article
Open access
PDF file
MMMasaki Miyasaka
Masaki Miyasaka
NTNorio Tada
Norio Tada
MTMasataka Taguri
Masataka Taguri
SKShigeaki Kato
Shigeaki Kato
YEYusuke Enta
Yusuke Enta
KHKentaro Hayashida
Kentaro Hayashida
Background: The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis–patient mismatch (PPM) more frequently occurs in S3 than XT. Further, little information is available on PPM after TAVI using S3 in Asians. This study aims to determine the incidence and predictors of PPM in S3 by focusing on the difference between S3 and XT using data from a Japanese multicentre registry. Methods: From the Optimised transCathEter vAlvular iNtervention-TAVI (OCEAN-TAVI) registry, 2134 patients undergoing TAVI using S3 or XT were included. PPM was defined as moderate if ≧0.65 but ≦0.85 cm2/m2 or severe if <0.65 cm2/m2 at the indexed effective orifice area by postprocedural echocardiography. Results: The incidence of moderate and severe PPM in S3 was 13.3% and 1.3%, respectively. The 20 mm transcatheter heart valve (THV) was more frequently used in S3 than XT (7.4% vs 2.4%, p<0.0001). PPM was more frequently observed in S3 than XT (14.7% vs 8.8%, p<0.0001). Multivariate logistic regression analysis revealed S3 predicted PPM (OR 1.92 (95% CI 1.35 to 2.74), p=0.0003). The mutual predictors for PPM between S3 and XT were younger age, larger body surface area, smaller aortic valve area, no balloon postdilatation and the use of 20 mm and 23 mm THV. When comparing 23 mm, 26 mm and 29 mm S3, the ORs of 20 mm S3 were 5.67 (95% CI 2.88 to 11.12), 19.24 (95% CI 8.13 to 46.86) and 51.03 (95% CI 12.28 to 280.77), respectively. Conclusions: The incidence of PPM after TAVI using S3 was 14.6% overall in this Asian population. PPM was more frequently observed in S3 than XT. A considerable number of patients were treated by the 20 mm S3 in an Asian cohort. The 20 mm THV was identified as a strong predictor for PPM.

10 July 2019 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
NTNorio Tada
Norio Tada
NTNaoyuki Tanaka
Naoyuki Tanaka
KAKazuo Abe
Kazuo Abe
MHMasaki Hata
Masaki Hata
Background: Aortic valve neocuspidization (AVNeo), a novel surgical procedure used in the treatment of aortic valve diseases, including aortic stenosis (AS), involves the replacement of three aortic valve cusps by glutaraldehyde-treated autologous pericardium. Although reoperation risk is low, no case report on the deterioration of the AVNeo has yet been published. Case summary: An 80-year-old woman who underwent AVNeo for severe degenerative tricuspid AS 6 years previously complained of shortness of breath. Echocardiographic assessment revealed the reconstructed aortic valve leaflet was elongated, thickened, and marginally calcified resulting in recurrent severe AS. Transcatheter aortic valve implantation using balloon-expandable transcatheter heart valve was successfully performed. Discussion: To our knowledge, this is the first case report regarding the structural deterioration of the AVNeo resulting in restenosis 6 years after the first surgery. Transcatheter aortic valve implantation is possibly a suitable approach for post-procedural recurrence after AVNeo to avoid redo open-heart surgery which would be of prohibitive risk especially in an elderly population.

25 April 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
MNMasahiko Noguchi
Masahiko Noguchi
MTMinoru Tabata
Minoru Tabata
KOKotaro Obunai
Kotaro Obunai
KSKentaro Shibayama
Kentaro Shibayama
JIJoji Ito
Joji Ito
KHKentaro Hayashida
Kentaro Hayashida